Isomerase Overview
- Year Founded
-
2012

- Status
-
Private
- Employees
-
37

- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$155K
- Investors
-
2
Isomerase General Information
Description
Operator of a pharmaceutical drug company intended to support partners across all aspects of microbial product and process discovery and development. The company offers a comprehensive suite of services including drug discovery, with a strong focus on biotechnology, specialize in synthetic biology, microbial strain development, microbial genome editing, enzyme engineering, directed evolution, cell-free protein synthesis, enzyme manufacturing, fermentation optimization, and downstream process development with a capability extended to producing a wide range of products, from natural compounds and peptides to enzymes, agricultural goods, and consumer products by bridging advanced-stage concepts to valuable development program, providing the healthcare sector and patients with advanced-stage concepts into valuable development programs.
Contact Information
Website
www.isomerase.comCorporate Office
- Newnham Building, First Floor
- Chesterford Research Park
- Cambridge CB10 1XL
- England, United Kingdom
Corporate Office
- Newnham Building, First Floor
- Chesterford Research Park
- Cambridge CB10 1XL
- England, United Kingdom
Isomerase Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
7. Grant | 01-Sep-2017 | $155K | Completed | Generating Revenue | ||
6. Grant | 01-Feb-2017 | Completed | Generating Revenue | |||
5. Early Stage VC | 15-Aug-2016 | Completed | Generating Revenue | |||
4. Grant | 01-Jun-2016 | Completed | Startup | |||
3. Grant | 01-Apr-2015 | Completed | Startup | |||
2. Angel (individual) | 12-Nov-2014 | $254K | $254K | Completed | Startup | |
1. Grant | 01-Nov-2014 | $242K | Completed | Startup |
Isomerase Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Ordinary |
Isomerase Comparisons
Industry
Financing
Details
Isomerase Competitors (2)
One of Isomerase’s 2 competitors is Amyris, a Private Equity-Backed company based in Emeryville, CA.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Amyris | Private Equity-Backed | Emeryville, CA | ||||
Ginkgo Bioworks | Formerly VC-backed | Boston, MA |
Isomerase Patents
Isomerase Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
GB-202414984-D0 | Novel methods | Pending | 11-Oct-2024 | ||
GB-202300816-D0 | Novel method | Inactive | 19-Jan-2023 | ||
GB-202300632-D0 | Novel methods | Inactive | 16-Jan-2023 | ||
GB-202200889-D0 | Novel methods | Inactive | 24-Jan-2022 | ||
GB-202101009-D0 | Novel methods | Inactive | 26-Jan-2021 |
Isomerase Signals
Isomerase Investors (2)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Abliva | Corporation | Minority | ||
Innovate UK | Government |
Isomerase FAQs
-
When was Isomerase founded?
Isomerase was founded in 2012.
-
Where is Isomerase headquartered?
Isomerase is headquartered in Cambridge, United Kingdom.
-
What is the size of Isomerase?
Isomerase has 37 total employees.
-
What industry is Isomerase in?
Isomerase’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is Isomerase a private or public company?
Isomerase is a Private company.
-
What is Isomerase’s current revenue?
The current revenue for Isomerase is
. -
How much funding has Isomerase raised over time?
Isomerase has raised $1.89M.
-
Who are Isomerase’s investors?
Abliva and Innovate UK have invested in Isomerase.
-
Who are Isomerase’s competitors?
Amyris and Ginkgo Bioworks are competitors of Isomerase.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »